Preclinical Drug Videos
-
BIT225 active against SARS-CoV-2 in an animal model of COVID-19 - Video
Biotron Limited (ASX:BIT) held a webinar today to update investors on its latest news on its lead clinical stage antiviral drug BIT225. BIT225 has shown significant and clinically relevant activity in an animal model of COVID-19. The drug prevented the development of severe disease, reduced pro-inflammatory cytokines associated with "cytokine storms" that are linked to severe disease and ...
-
ARM`s 2022 Cell & Gene State of the Industry Briefing - Video
The Alliance for Regenerative Medicine’s annual Cell & Gene State of the Industry Briefing, a top-level gathering for key stakeholders in the field. This webinar includes ARM’s annual yearly update on the sector’s progress, followed by two panel sessions featuring top CEOs and executives highlighting future inflection points for cell and gene therapies in the coming year. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you